Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,130 JPY | -0.19% | +0.02% | +1.87% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
Sales 2024 | 4,264B 27.39B | Sales 2025 * | 4,076B 26.18B | Capitalization | 6,480B 41.62B |
---|---|---|---|---|---|
Net income 2024 | 144B 925M | Net income 2025 * | 155B 998M | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.22B | Net Debt 2025 * | 4,027B 25.87B | EV / Sales 2025 * | 2.58 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
40.7
x | Employees | 49,095 |
Yield 2024 * |
4.55% | Yield 2025 * |
4.61% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | -0.19% | ||
1 week | +1.47% | ||
Current month | -0.55% | ||
1 month | +0.22% | ||
3 months | -6.39% | ||
6 months | -0.43% | ||
Current year | +1.87% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 19 M€ | +11.32% | ||
5.00% | 288 M€ | +24.13% | ||
3.80% | 1,531 M€ | +20.49% | ||
3.43% | 240 M€ | +17.87% | ||
3.26% | 60 M€ | +22.66% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4,130 | -0.19% | 3,239,600 |
24-05-16 | 4,138 | -0.50% | 3,260,400 |
24-05-15 | 4,159 | -1.09% | 2,815,500 |
24-05-14 | 4,205 | +2.51% | 5,511,800 |
24-05-13 | 4,102 | -0.65% | 5,677,600 |
Delayed Quote Japan Exchange, May 17, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.87% | 41.81B | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- 4502 Stock